Last reviewed · How we verify

NCT06031545

An Exploratory Study of Perioperative Venous Access in Obese Patients

Status unknown NA Last updated 11 September 2023
What this trial tests

NA trial testing Long peripheral venous catheters for use in Catheter Complications in 528 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
30 November 2025
30 December 2025

Quick facts

Lead sponsorSir Run Run Shaw Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment528
Start date1 December 2023
Primary completion30 November 2025
Estimated completion30 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sir Run Run Shaw Hospital

Who can join

Eligibility, any sex, with Catheter Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is intended to explore the application effect of long peripheral intravenous catheters(LPCs) and midline catheters(MCs) in the perioperative period of obese patients, aiming at providing the scientific basis for the optimal perioperative venous access for the obese patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparative safety and efficacy of midline catheters versus long peripheral catheters in patients undergoing bariatric surgery: a randomised controlled trial.
    Zhao L, Yang X, Liu C, Yu W, et al · · 2025 · PMID 40835653 · DOI 10.1038/s41598-025-12551-0

Verify or expand the search:

Other recruiting trials for Catheter Complications

Currently open trials in the same condition.

Other Sir Run Run Shaw Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031545.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing